BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7004570)

  • 1. [Lymphocytotoxic antibodies in patients after kidney transplantation (author's transl)].
    Niks M; Stefanovic J; Nyulassy S; Buc M; Breza J
    Bratisl Lek Listy; 1980 Nov; 74(5):541-6. PubMed ID: 7004570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of lymphocytotoxic antibodies in kidney transplantation revisited (author's transl)].
    Gluckman JC; Foucault C; Patte R; Frantz P; Bedrossian J; Nebout T; Chapuis F; Klatzmann D; Gomez AM
    Nouv Presse Med; 1981 Feb; 10(5):303-7. PubMed ID: 7015277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
    Drannik GN; Driianskaia VE; Montag TS
    Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 5. [Retrospective analysis of the survival of the transplanted kidney as a function of the content of anti-T- and anti-B-lymphocytotoxic antibodies in the blood serum of recipients and in eluates obtained from kidney allotransplants].
    Drannik GN; Montag TS; Driianskaia VE; Lastovets LN
    Fiziol Zh (1978); 1988; 34(1):66-71. PubMed ID: 3284768
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal transplantation and anti-B lymphocyte antibodies. II. Relation between acute rejection and development of B lymphocyte cytotoxic antibodies following transplantation].
    Kinukawa T; Ohshima S; Ono Y; Matsuura O; Hirabayashi S; Takeuchi N; Ogawa H; Hattori R
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1179-85. PubMed ID: 6363786
    [No Abstract]   [Full Text] [Related]  

  • 7. The development and specificity of anti-B-cell antibodies during humoral rejection of kidney allografts.
    Hardy M; Suciu-Foca N; McKiernan T; Rohowsky C; Cianci J; Jacob J; Pierce J; Reemtsma K
    Transplant Proc; 1979 Mar; 11(1):389-92. PubMed ID: 377661
    [No Abstract]   [Full Text] [Related]  

  • 8. B-lymphocyte-specific antibodies in human renal allografts.
    Mohanakumar T; Giedlin M; DuVall C; Rhodes C; Phibbs M; Mendez G; Kaplan AM; Lee HM
    Transplant Proc; 1979 Mar; 11(1):397-400. PubMed ID: 377664
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre- and posttransplant B-cell antibodies in renal transplantation.
    Ting A; Morris PJ
    Transplant Proc; 1979 Mar; 11(1):393-6. PubMed ID: 377663
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of lymphocytotoxic antibodies in renal transplantation.
    Roy R; Lachance JG; Fradet Y; Hebert J
    Transplantation; 1981 Jan; 31(1):31-3. PubMed ID: 7015597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 14. [The complement system in experimental and clinical kidney transplantation (author's transl)].
    Kux M
    Wien Klin Wochenschr; 1974 Jan; 86(2):29-39. PubMed ID: 4613019
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of autoreactive lymphocytotoxic antibodies in sensitised dialysis and kidney transplant patients.
    Barocci S; Nocera A; Carozzi S; Leprini A; Fontana I; Armani R; Valente U; Lamperi S; Celada F
    Nephrol Dial Transplant; 1987; 2(4):266-70. PubMed ID: 2823188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of the rosette inhibition test in renal allotransplantation.
    Cantaluppi A; Tarantino A; Donati D; Ponticelli C
    Transplant Proc; 1979 Mar; 11(1):379-81. PubMed ID: 377660
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent perspectives on the mechanisms of rejection in kidney transplantation (author's transl)].
    Lenhard V; Resch K; Dreikorn K; Ritz E
    Klin Wochenschr; 1978 Jan; 56(2):51-60. PubMed ID: 342812
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocytotoxic antibodies in 1500 potential first kidney transplant recipients.
    Lieber SR; Gerbase-DeLima M; Persoli LB; Pedro-Filho F; Setta JH; Montagna W; Pestana JO
    Transplant Proc; 1992 Dec; 24(6):3072-3. PubMed ID: 1466060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.